Innovation Pharmaceuticals Inc (IPIX)

[oddone33320]

With regard to the single, possible SAE in the Brilacidin trial what are the implications if it was in one of the B arms? Specifically, with regard to FDA and moving forward into Phase 3? Does it take more than 1 SAE to be considered a cause for concern by the FDA when planning additional trials?